Gamida Cell Ltd. (GMDA)
NASDAQ: GMDA · IEX Real-Time Price · USD
0.0361
-0.0231 (-39.02%)
At close: Mar 28, 2024, 4:00 PM
0.0383
+0.0022 (6.09%)
After-hours: Mar 28, 2024, 7:59 PM EDT
Gamida Cell Market Cap
Gamida Cell has a market cap or net worth of $7.85 million as of March 28, 2024. Its market cap has decreased by -92.87% in one year.
Market Cap
7.85M
Enterprise Value
41.19M
1-Year Change
-92.87%
Ranking
Category
Stock Price
$0.04
Market Cap Chart
Since October 26, 2018, Gamida Cell's market cap has decreased from $156.00M to $7.85M, a decrease of -94.97%. That is a compound annual growth rate of -42.38%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 9.10M | -80.00% |
Mar 26, 2024 | 45.50M | 1.56% |
Mar 25, 2024 | 44.80M | -12.67% |
Mar 22, 2024 | 51.30M | -4.11% |
Mar 21, 2024 | 53.50M | 7.21% |
Mar 20, 2024 | 49.90M | -3.29% |
Mar 19, 2024 | 51.60M | 5.09% |
Mar 18, 2024 | 49.10M | 15.80% |
Mar 15, 2024 | 42.40M | -1.62% |
Mar 14, 2024 | 43.10M | -7.51% |
Mar 13, 2024 | 46.60M | 12.56% |
Mar 12, 2024 | 41.40M | -8.20% |
Mar 11, 2024 | 45.10M | -0.66% |
Mar 8, 2024 | 45.40M | 1.57% |
Mar 7, 2024 | 44.70M | -3.66% |
Mar 6, 2024 | 46.40M | -2.73% |
Mar 5, 2024 | 47.70M | 1.49% |
Mar 4, 2024 | 47.00M | -7.48% |
Mar 1, 2024 | 50.80M | 6.50% |
Feb 29, 2024 | 47.70M | -1.65% |
Feb 28, 2024 | 48.50M | -4.34% |
Feb 27, 2024 | 50.70M | 0.60% |
Feb 26, 2024 | 50.40M | 12.50% |
Feb 23, 2024 | 44.80M | -5.68% |
Feb 22, 2024 | 47.50M | -2.46% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Lucid Diagnostics | 47.52M |
Cellectar Biosciences | 47.31M |
ReWalk Robotics | 46.29M |
Aptorum Group | 45.86M |
Dyadic International | 45.52M |
Bolt Biotherapeutics | 45.37M |
Regencell Bioscience Holdings | 44.89M |
Bright Green | 44.57M |